Adaptive trials in the neoadjuvant setting: A model to safely tailor care while accelerating drug development

Douglas Yee, Tufia Haddad, Kathy Albain, Anna Barker, Christopher Benz, Judy Boughey, Meredith Buxton, Amy Jo Chien, Angela DeMichele, David Dilts, Anthony Elias, Paul Haluska, Michael Hogarth, Alan Hu, Nola Hytlon, Henry G. Kaplan, Gary G. Kelloff, Qamar Khan, Julie Lang, Brian Leyland-JonesMinetta Liu, Rita Nanda, Donald Northfelt, Olufunmilayo I. Olopade, John Park, Barbara Parker, David Parkinson, Sonia Pearson-White, Jane Perlmutter, Lajos Pusztai, Fraser Symmans, Hope Rugo, Debu Tripathy, Anne Wallace, David Wholley, Laura Van't Veer, Donald A. Berry, Laura Esserman

Research output: Contribution to journalLetter

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)4584-4586
Number of pages3
JournalJournal of Clinical Oncology
Volume30
Issue number36
DOIs
StatePublished - Dec 20 2012

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yee, D., Haddad, T., Albain, K., Barker, A., Benz, C., Boughey, J., Buxton, M., Chien, A. J., DeMichele, A., Dilts, D., Elias, A., Haluska, P., Hogarth, M., Hu, A., Hytlon, N., Kaplan, H. G., Kelloff, G. G., Khan, Q., Lang, J., ... Esserman, L. (2012). Adaptive trials in the neoadjuvant setting: A model to safely tailor care while accelerating drug development. Journal of Clinical Oncology, 30(36), 4584-4586. https://doi.org/10.1200/JCO.2012.44.1022